130 related articles for article (PubMed ID: 28229437)
21. Region- and voxel-based quantification in human brain of [
Lee JH; Veronese M; Liow JS; Morse CL; Montero Santamaria JA; Haskali MB; Zoghbi SS; Pike VW; Innis RB; Zanotti-Fregonara P
EJNMMI Res; 2021 Apr; 11(1):35. PubMed ID: 33796956
[TBL] [Abstract][Full Text] [Related]
22. Small-animal PET study for noninvasive quantification of transmembrane AMPA receptor regulatory protein
Yamasaki T; Ishii H; Hiraishi A; Kumata K; Wakizaka H; Zhang Y; Kurihara Y; Ogawa M; Nengaki N; Chen J; Li Y; Liang S; Zhang MR
J Cereb Blood Flow Metab; 2023 Jun; 43(6):893-904. PubMed ID: 36655318
[TBL] [Abstract][Full Text] [Related]
23. Kinetic modeling and long-term test-retest reproducibility of the mGluR5 PET tracer 18F-FPEB in human brain.
Leurquin-Sterk G; Postnov A; de Laat B; Casteels C; Celen S; Crunelle CL; Bormans G; Koole M; Van Laere K
Synapse; 2016 Apr; 70(4):153-62. PubMed ID: 26799447
[TBL] [Abstract][Full Text] [Related]
24. The Search for a Subtype-Selective PET Imaging Agent for the GABA
Lin SF; Bois F; Holden D; Nabulsi N; Pracitto R; Gao H; Kapinos M; Teng JK; Shirali A; Ropchan J; Carson RE; Elmore CS; Vasdev N; Huang Y
Mol Imaging; 2017; 16():1536012117731258. PubMed ID: 28929924
[TBL] [Abstract][Full Text] [Related]
25. Tracer Kinetic Analysis of (S)-¹⁸F-THK5117 as a PET Tracer for Assessing Tau Pathology.
Jonasson M; Wall A; Chiotis K; Saint-Aubert L; Wilking H; Sprycha M; Borg B; Thibblin A; Eriksson J; Sörensen J; Antoni G; Nordberg A; Lubberink M
J Nucl Med; 2016 Apr; 57(4):574-81. PubMed ID: 26795290
[TBL] [Abstract][Full Text] [Related]
26. Measurement of GABAA receptor binding in vivo with [11C]flumazenil: a test-retest study in healthy subjects.
Salmi E; Aalto S; Hirvonen J; Långsjö JW; Maksimow AT; Oikonen V; Metsähonkala L; Virkkala J; Någren K; Scheinin H
Neuroimage; 2008 Jun; 41(2):260-9. PubMed ID: 18411060
[TBL] [Abstract][Full Text] [Related]
27. Validation of an extracerebral reference region approach for the quantification of brain nicotinic acetylcholine receptors in squirrel monkeys with PET and 2-18F-fluoro-A-85380.
Le Foll B; Chefer SI; Kimes AS; Shumway D; Goldberg SR; Stein EA; Mukhin AG
J Nucl Med; 2007 Sep; 48(9):1492-500. PubMed ID: 17704243
[TBL] [Abstract][Full Text] [Related]
28. Parametric [11C]flumazenil images.
Klumpers UM; Boellaard R; Veltman DJ; Kloet RW; Hoogendijk WJ; Lammertsma AA
Nucl Med Commun; 2012 Apr; 33(4):422-30. PubMed ID: 22293497
[TBL] [Abstract][Full Text] [Related]
29. Quantifying SV2A density and drug occupancy in the human brain using [
Koole M; van Aalst J; Devrome M; Mertens N; Serdons K; Lacroix B; Mercier J; Sciberras D; Maguire P; Van Laere K
Eur J Nucl Med Mol Imaging; 2019 Feb; 46(2):396-406. PubMed ID: 30121895
[TBL] [Abstract][Full Text] [Related]
30. Quantification of GABAA receptors in the rat brain with [(123)I]Iomazenil SPECT from factor analysis-denoised images.
Tsartsalis S; Moulin-Sallanon M; Dumas N; Tournier BB; Ghezzi C; Charnay Y; Ginovart N; Millet P
Nucl Med Biol; 2014 Feb; 41(2):186-95. PubMed ID: 24405841
[TBL] [Abstract][Full Text] [Related]
31. PET quantification of 18F-florbetaben binding to β-amyloid deposits in human brains.
Becker GA; Ichise M; Barthel H; Luthardt J; Patt M; Seese A; Schultze-Mosgau M; Rohde B; Gertz HJ; Reininger C; Sabri O
J Nucl Med; 2013 May; 54(5):723-31. PubMed ID: 23471310
[TBL] [Abstract][Full Text] [Related]
32. [18F]Fluoroethylflumazenil: a novel tracer for PET imaging of human benzodiazepine receptors.
Gründer G; Siessmeier T; Lange-Asschenfeldt C; Vernaleken I; Buchholz HG; Stoeter P; Drzezga A; Lüddens H; Rösch F; Bartenstein P
Eur J Nucl Med; 2001 Oct; 28(10):1463-70. PubMed ID: 11685488
[TBL] [Abstract][Full Text] [Related]
33. Characterization of [
Yang KC; Stepanov V; Amini N; Martinsson S; Takano A; Nielsen J; Bundgaard C; Bang-Andersen B; Grimwood S; Halldin C; Farde L; Finnema SJ
Eur J Nucl Med Mol Imaging; 2017 Feb; 44(2):308-320. PubMed ID: 27817159
[TBL] [Abstract][Full Text] [Related]
34. Measurement of benzodiazepine receptor number and affinity in humans using tracer kinetic modeling, positron emission tomography, and [11C]flumazenil.
Price JC; Mayberg HS; Dannals RF; Wilson AA; Ravert HT; Sadzot B; Rattner Z; Kimball A; Feldman MA; Frost JJ
J Cereb Blood Flow Metab; 1993 Jul; 13(4):656-67. PubMed ID: 8391018
[TBL] [Abstract][Full Text] [Related]
35. Kinetic modeling of 11C-SB207145 binding to 5-HT4 receptors in the human brain in vivo.
Marner L; Gillings N; Comley RA; Baaré WF; Rabiner EA; Wilson AA; Houle S; Hasselbalch SG; Svarer C; Gunn RN; Laruelle M; Knudsen GM
J Nucl Med; 2009 Jun; 50(6):900-8. PubMed ID: 19470850
[TBL] [Abstract][Full Text] [Related]
36. Quantification of dopamine transporter binding using [18F]FP-beta-CIT and positron emission tomography.
Yaqub M; Boellaard R; van Berckel BN; Ponsen MM; Lubberink M; Windhorst AD; Berendse HW; Lammertsma AA
J Cereb Blood Flow Metab; 2007 Jul; 27(7):1397-406. PubMed ID: 17191076
[TBL] [Abstract][Full Text] [Related]
37. PET measurement of "GABA shift" in the rat brain: A preclinical application of bolus plus constant infusion paradigm of [
Kim W; Park HS; Moon BS; Lee BC; Kim SE
Nucl Med Biol; 2017 Feb; 45():30-34. PubMed ID: 27886620
[TBL] [Abstract][Full Text] [Related]
38. Benzodiazepine receptor quantification in vivo in humans using [11C]flumazenil and PET: application of the steady-state principle.
Lassen NA; Bartenstein PA; Lammertsma AA; Prevett MC; Turton DR; Luthra SK; Osman S; Bloomfield PM; Jones T; Patsalos PN
J Cereb Blood Flow Metab; 1995 Jan; 15(1):152-65. PubMed ID: 7798333
[TBL] [Abstract][Full Text] [Related]
39. Quantitative analysis of dopamine transporters in human brain using [11C]PE2I and positron emission tomography: evaluation of reference tissue models.
Seki C; Ito H; Ichimiya T; Arakawa R; Ikoma Y; Shidahara M; Maeda J; Takano A; Takahashi H; Kimura Y; Suzuki K; Kanno I; Suhara T
Ann Nucl Med; 2010 May; 24(4):249-60. PubMed ID: 20364374
[TBL] [Abstract][Full Text] [Related]
40. Preclinical Evaluation and Quantification of 18F-FPEB as a Radioligand for PET Imaging of the Metabotropic Glutamate Receptor 5.
de Laat B; Leurquin-Sterk G; Celen S; Bormans G; Koole M; Van Laere K; Casteels C
J Nucl Med; 2015 Dec; 56(12):1954-9. PubMed ID: 26405172
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
